MSLN and pancreatic neoplasm: Despite immunophenotypic differences, CD28ζ and 4-1BBζ CAR T-cells demonstrated similar efficacy in real-time cytotoxicity assays against the pancreatic cancer cell line, Capan2, which expresses MSLN natively (Fig. 1J) with > 95% tumour cell lysis at 48 h.